PCSK1 and triple-A syndrome: Having confirmed the protective property of Nec-1 against both necrosis and apoptosis in vivo, we next evaluated the effects of Nec-1 on aneurysm formation in mice by daily IP injections of Nec-1 (3.2 mg/kg/day), beginning 30 min before AAA induction (Fig. 2A).